Raymond Baker

Statistics

Publications

118

Citations

4.2K

H-Index

Active since

1968

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Southampton

Raymond Baker is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, chemistry, and organic chemistry.

Publications per year

1968–2005

118

Publications

118

3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D4 Receptor

Janusz J. Kulagowski, Howard B. Broughton, Neil R. Curtis et al. · Journal of Medicinal Chemistry · 1996 · 257 citations · Full text

Medicine, Pharmacology, Neurochemistry +4

Total synthesis of (+)-macbecin I

Raymond Baker, José L. Castro · Journal of the Chemical Society Perkin Transactions 1 · 1990 · 159 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Novel quinuclidine-based ligands for the muscarinic cholinergic receptor

John Saunders, Stephen B. Freedman, Elizabeth A. Harley et al. · Journal of Medicinal Chemistry · 1990 · 158 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Identification and synthesis of the major sex pheromone of the olive fly (Dacus oleae)

Raymond Baker, Richard H. Herbert, P. E. Howse et al. · Journal of the Chemical Society Chemical Communications · 1980 · 140 citations

Life Sciences, Biochemistry, Entomology +12

Effect of Plasma Protein Binding on in Vivo Activity and Brain Penetration of Glycine/NMDA Receptor Antagonists

Michael Rowley, Janusz J. Kulagowski, Alan P. Watt et al. · Journal of Medicinal Chemistry · 1997 · 129 citations

Medicine, Neuroscience, Pharmacology +17

1–5 of 118